Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5877)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2014 (publication date) through Dec 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Liu GF, Tang D, Li P, Wang S, Xu YX, Long AH, Zhou NL, Zhang LL, Chen J, Xiang XX. S-1-based combination therapy |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i1/310.htm |
| Number | Citing Articles |
| 1 |
YAN HOU, JUNWEN ZHEN, XIAODONG XU, KUN ZHEN, BIN ZHU, RUI PAN, CHIDONG ZHAO. miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer. Oncology Letters 2015; 10(4): 1985 doi: 10.3892/ol.2015.3587
|
| 2 |
Ning-ning Bian, Yong-hong Wang, Guang-tao Min. S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysis. International Journal of Surgery 2019; 62: 34 doi: 10.1016/j.ijsu.2018.11.010
|
| 3 |
Fabiana G. Curea, Mohamed Hebbar, Silvia M. Ilie, Xenia E. Bacinschi, Oana G. Trifanescu, Inga Botnariuc, Rodica M. Anghel. Current Targeted Therapies in HER2-Positive Gastric Adenocarcinoma. Cancer Biotherapy and Radiopharmaceuticals 2017; 32(10): 351 doi: 10.1089/cbr.2017.2249
|
| 4 |
Yuan Zhang, Jiangang Wang, Wenzhi An, Chen Chen, Wencheng Wang, Chao Zhu, Fangzhou Chen, Huizhao Chen, Wei Zheng, Jie Gong. MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma. Technology in Cancer Research & Treatment 2019; 18 doi: 10.1177/1533033819854132
|
| 5 |
Qian Zhang, Qinghua Zhang, Hui Yan, Yanjie You, Juan Cao, Wenfan Wang, Dan Zhao, Xiaoxu Zhang, Jing Wu, Zhiqiang Chen, Wenjun Yang. Survival Advantages in Gastric Cancer Patients Receiving Preoperative SOX Regimen Chemotherapy. Cancer Biotherapy and Radiopharmaceuticals 2023; 38(2): 81 doi: 10.1089/cbr.2020.3970
|
| 6 |
Yue Zhao, Wangqing Chen, Wu Zhu, Jie Li, Juan Su, Shuang Zhao, Mingliang Chen, Jianglin Zhang, Aiyuan Guo, Siyu Yan, Xingchen Zhou, Xinwei Kuang, Zhaoqian Liu, Dan Luo, Todd C Knepper, Yijing He, Xiang Chen.
Tandem Repeats of
TSER
Significantly Influence the Efficacy of 5-Fluorouracil in the Treatment of Plantar Warts
. Personalized Medicine 2016; 13(3): 233 doi: 10.2217/pme-2015-0014
|
| 7 |
Fang-Lan Wu, De-Cheng Lu, Yan-Ping Ying, Jin-Jiao Huang, Ai-Min Zhou, Dun-Ke Jiang, Mao-Wei Chen, Xi Yang, Jia Zhou, Hui-Qiao Huang, Hong-Yan Zeng. A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer. Medicine 2015; 94(16): e652 doi: 10.1097/MD.0000000000000652
|
| 8 |
Deng-Yan Zhu, Xiang-Nan Li, Yu Qi, Dong-Lei Liu, Yang Yang, Jia Zhao, Chun-Yang Zhang, Kai Wu, Song Zhao. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN. Biomedicine & Pharmacotherapy 2016; 81: 79 doi: 10.1016/j.biopha.2016.03.029
|
| 9 |
Zhu Li, Xu Hou, Juan Chen, Huidong Sun, Yuetang Mi, Yongling Sui, Yuhong Li, Jiaping Xie, Yingli Qiao, Xiaofeng Lei, Xiaoshuang Che, Jun Liu. Efficacy and safety of SOX chemotherapy with or without surgery in AFP-producing advanced gastric cancer. Oncology Letters 2017; 14(1): 579 doi: 10.3892/ol.2017.6240
|
| 10 |
Jin Xiao. MiR-32 Functions as a Tumor Suppressor and Directly Targets EZH2 in Human Oral Squamous Cell Carcinoma. Medical Science Monitor 2014; 20: 2527 doi: 10.12659/MSM.892636
|
| 11 |
Changshan Song, Pingfang Lu, Weicheng Shi, Guoqiang Sun, Guangsuo Wang, Xujie Huang, Zheng Wang, Zhigang Wang. MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy 2016; 83: 843 doi: 10.1016/j.biopha.2016.07.036
|
| 12 |
Hiromi Nagano, Yuichi Kurono, Kakushi Matushita. Adult T-cell leukemia/lymphoma in patients with head and neck cancer after S-1 chemotherapy. Auris Nasus Larynx 2017; 44(2): 195 doi: 10.1016/j.anl.2016.05.002
|
| 13 |
Jinping Sun, Zheng Ren, Xinfang Sun, Hongtao Hou, Ke Li, Quanxing Ge. Efficacy and safety comparison of chemotherapies for advanced gastric cancer: A network meta-analysis. Oncotarget 2017; 8(24): 39673 doi: 10.18632/oncotarget.17784
|
| 14 |
Dongsheng Zhao, Rencong Wang, Junkang Fang, Xituan Ji, Juan Li, Xiaoyan Chen, Gangfeng Sun, Zhengjun Wang, Weiping Liu, Yangang Wang, Guang Cheng, Haining Zhen, Chunhua Sun, Zhou Fei. RETRACTED ARTICLE: MiR-154 Functions as a Tumor Suppressor in Glioblastoma by Targeting Wnt5a. Molecular Neurobiology 2017; 54(4): 2823 doi: 10.1007/s12035-016-9867-5
|
| 15 |
Ziming Zhao, Erxun Dai, Bao Jin, Ping Deng, Zulihaer Salehebieke, Bin Han, Rongfan Wu, Zhaowu Yu, Jun Ren. A prognostic nomogram to predict the cancer-specific survival of patients with initially diagnosed metastatic gastric cancer: a validation study in a Chinese cohort. Clinical and Translational Oncology 2024; doi: 10.1007/s12094-024-03576-4
|
| 16 |
Emil ter Veer, Nadia Haj Mohammad, Paul Lodder, Lok Lam Ngai, Mary Samaan, Martijn G. H. van Oijen, Hanneke W. M. van Laarhoven. The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis. Gastric Cancer 2016; 19(3): 696 doi: 10.1007/s10120-015-0587-8
|
| 17 |
S.M.Zeeshan Qadar, Zhiyong Dong, Sheikh Mohammed Shariful Islam, Jianxue Wang, Xiling Xu, Fakhsheena Anjum, Sana Shamim, Bafreen Sherif, Sundas Ali. S-1 plus oxaloplatin (S-1OX) versus capecitabine plus oxaloplatin (CAPOX) for advanced gastric cancer: A systematic review and meta-analysis. Computer Methods and Programs in Biomedicine Update 2024; 5: 100151 doi: 10.1016/j.cmpbup.2024.100151
|
| 18 |
Xiaolong Qi, Yanna Liu, Wei Wang, Danxian Cai, Wende Li, Jialiang Hui, Chuan Liu, Yanxia Zhao, Guoxin Li. Management of advanced gastric cancer: An overview of major findings from meta-analysis. Oncotarget 2016; 7(47): 78180 doi: 10.18632/oncotarget.12102
|
| 19 |
Yang Kai, Cheng Qiang, Pan Xinxin, Zhou Miaomiao, Lin Kuailu. RETRACTED ARTICLE: Decreased miR-154 expression and its clinical significance in human colorectal cancer. World Journal of Surgical Oncology 2016; 13(1) doi: 10.1186/s12957-015-0607-5
|